These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 4937943

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Transplantation immunity (allergy) II. Methods for the prolongation of the viability of the homograft].
    Rajka O.
    Orv Hetil; 1968 Feb 04; 109(5):225-30. PubMed ID: 5686747
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Renal allotransplantation in humans. Results and prospects from 72 cases].
    Kuss R, Legrain M, Gluckman JC, Guedon J, Poisson J.
    Presse Med (1893); 1971 Oct 16; 79(43):1889-94. PubMed ID: 4942801
    [No Abstract] [Full Text] [Related]

  • 47. [Therapy with organ transplants: current possibilities and future prospects. II].
    Cairella M, Volpari B.
    Clin Ter; 1971 May 15; 57(3):249-84. PubMed ID: 4942256
    [No Abstract] [Full Text] [Related]

  • 48. Donor cells that facilitate tolerance to rat heart allografts after posttransplant total lymphoid irradiation and rabbit anti-thymocyte globulin.
    Hayamizu K, Zeng D, Strober S.
    Transplant Proc; 1999 May 15; 31(3B Suppl):25S-26S. PubMed ID: 10330965
    [No Abstract] [Full Text] [Related]

  • 49. Prolongation of murine cardiac allografts with antilymphocyte serum.
    Judd KP, Allen CR, Guiberteau MJ, Trentin JJ.
    Transplant Proc; 1969 Mar 15; 1(1):470-3. PubMed ID: 4944262
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Immunology of transplantation.
    Ritzmann SE, Daniels JC.
    Tex Med; 1970 May 15; 66(5):48-53. PubMed ID: 4913546
    [No Abstract] [Full Text] [Related]

  • 52. [Renal allotransplantation in man. Methods of conditioning and analysis of the complications in 72 cases, of which 51 received antilymphocyte globulins].
    Kuss R, Legrain M, Gluckman JC, Thibault P.
    Minerva Chir; 1971 Jul 15; 26(13):721-34. PubMed ID: 4935931
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E, Alfani D, Monari C, Trovati A, Berloco P, Famulari A, Cucchiara G, Cortesini R.
    Minerva Chir; 1980 May 31; 35(10):747-50. PubMed ID: 7005730
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Human renal transplantation: current status and prognosis.
    Braun WE.
    Med Ann Dist Columbia; 1970 Jun 31; 39(6):295-302. PubMed ID: 4914291
    [No Abstract] [Full Text] [Related]

  • 59. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI, Verbitskiĭ MSh, Artsimovich NG, Kipervasser EM, Lagutina NIa.
    Probl Gematol Pereliv Krovi; 1972 Feb 31; 17(2):42-50. PubMed ID: 4558981
    [No Abstract] [Full Text] [Related]

  • 60. [Organ transplantation in man].
    Zenker R, Pichlmaier H.
    Minerva Med; 1969 May 09; 60(37):1833-40. PubMed ID: 4892467
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.